TLSA

Tiziana Life Sciences Ltd Com

• Benzinga·04/01 17:10

  Tiziana Life Sciences Stock Jumps As Positive Preclinical Fuels Momentum

• TipRanks·04/01 12:42

  Tiziana Life Sciences Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline

• Reuters·04/01 11:00

  Tiziana says preclinical data show intranasal foralumab reverses brain aging, boosts cognition

• Benzinga·03/26 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session

• Reuters·03/19 01:18

  Tiziana Life Sciences Ltd. Director and 10% Owner Gabriele M. Cerrone Files Initial Beneficial Ownership Statement

• Reuters·02/25 18:48

  BUZZ-U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara

• Reuters·02/25 15:46

  BUZZ-U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin

• Reuters·02/25 14:39

  BUZZ-U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight

• TipRanks·02/25 12:28

  Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS

• TipRanks·02/25 12:25

  Tiziana Life Sciences announces new data on nasal foralumab

• Reuters·02/25 12:00

  Tiziana reports biomarker data linking nasal foralumab to reduced CSF inflammation and microglial PET signal in na-SPMS patients with PIRA

• Reuters·02/25 12:00

  TIZIANA LIFE SCIENCES ANNOUNCES NEW BIOMARKER DATA SHOWING NASAL FORALUMAB DOWNREGULATES CSF INFLAMMATION, UPREGULATES NEUROPROTECTIVE PATHWAYS, AND CORRELATES WITH REDUCED MICROGLIAL ACTIVATION ON PET SCANS IN NA-SPMS PATIENTS WITH PIRA

• NASDAQ·01/21 09:41

  Tiziana's Intranasal Foralumab Study Results Published In Peer-Reviewed Journal

• TipRanks·01/20 16:48

  Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal

• TipRanks·01/20 16:20

  Tiziana Life Sciences announces publication of intranasal foralumab results